Cleared Special

K142011 - SOLUTION SET/EXTENSION SET

K142011 is the FDA 510(k) clearance for SOLUTION SET/EXTENSION SET by Baxter Healthcare Corporation. It is a Class 2 General Hospital device (product code FPA) cleared through the Special 510(k) pathway after a 25-day FDA review.

K142011 · Baxter Healthcare Corporation · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2014
Decision
25d
Days
Class 2
Risk

K142011 is an FDA 510(k) clearance for the SOLUTION SET/EXTENSION SET. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Baxter Healthcare Corporation (Round Lake, US). The FDA issued a Cleared decision on August 18, 2014 after a review of 25 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Baxter Healthcare Corporation devices

Submission Details

510(k) Number K142011 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 24, 2014
Decision Date August 18, 2014
Days to Decision 25 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
104d faster than avg
Panel avg: 129d · This submission: 25d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 453
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K142011.
Hospira Primary Sets
K142367 · Hospira, Inc. · Nov 2014
MaxZero Administration Sets
K143234 · Care Fusion · Nov 2014
INFUSOMAT SPACE VOLUMETRIC INFUSION PUMP ADMINISTRATION SETS
K142036 · B.Braun Medical, Inc. · Aug 2014
CARESITE LUER ACCESS DEVICE
K140311 · B.Braun Medical, Inc. · May 2014
MAXZERO EXTENSION SET WITH NEEDLESS CONNECTOR
K140831 · Care Fusion · Apr 2014
MEDCOMP POWER INJECTABLE SAFETY HUBER NEEDLE
K132880 · Medical Components, Inc. · Jan 2014